Shimizu E - Search Results

1

Impact of pathological tumor stage for salvage radiotherapy after radical prostatectomy in patients with prostate-specific antigen < 1.0 ng/ml.

Umezawa R, Ariga H, Ogawa Y, Jingu K, Matsushita H, Takeda K, Fujimoto K, Sakayauchi T, Sugawara T, Kubozono M, Narazaki K, Shimizu E, Takai Y, Yamada S. Umezawa R, et al. Among authors: shimizu e. Radiat Oncol. 2011 Nov 5;6:150. doi: 10.1186/1748-717X-6-150. Radiat Oncol. 2011. PMID: 22053922 Free PMC article.

2

Intraoperative radiotherapy for pancreatic cancer: 30-year experience in a single institution in Japan.

Jingu K, Tanabe T, Nemoto K, Ariga H, Umezawa R, Ogawa Y, Takeda K, Koto M, Sugawara T, Kubozono M, Shimizu E, Abe K, Yamada S. Jingu K, et al. Among authors: shimizu e. Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):e507-11. doi: 10.1016/j.ijrobp.2012.01.024. Epub 2012 Mar 22. Int J Radiat Oncol Biol Phys. 2012. PMID: 22445002

3

Treatment outcome of high-dose image-guided intensity-modulated radiotherapy using intra-prostate fiducial markers for localized prostate cancer at a single institute in Japan.

Takeda K, Takai Y, Narazaki K, Mitsuya M, Umezawa R, Kadoya N, Fujita Y, Sugawara T, Kubozono M, Shimizu E, Abe K, Shirata Y, Ishikawa Y, Yamamoto T, Kozumi M, Dobashi S, Matsushita H, Chida K, Ishidoya S, Arai Y, Jingu K, Yamada S. Takeda K, et al. Among authors: shimizu e. Radiat Oncol. 2012 Jul 6;7:105. doi: 10.1186/1748-717X-7-105. Radiat Oncol. 2012. PMID: 22770471 Free PMC article.

4

Patient-Specific Quality Assurance Using Monte Carlo Dose Calculation and Elekta Log Files for Prostate Volumetric-Modulated Arc Therapy.

Katsuta Y, Kadoya N, Fujita Y, Shimizu E, Matsunaga K, Sawada K, Matsushita H, Majima K, Jingu K. Katsuta Y, et al. Among authors: shimizu e. Technol Cancer Res Treat. 2017 Dec;16(6):1220-1225. doi: 10.1177/1533034617745250. Epub 2017 Dec 5. Technol Cancer Res Treat. 2017. PMID: 29334027 Free PMC article.

5

Log file-based patient dose calculations of double-arc VMAT for head-and-neck radiotherapy.

Katsuta Y, Kadoya N, Fujita Y, Shimizu E, Majima K, Matsushita H, Takeda K, Jingu K. Katsuta Y, et al. Among authors: shimizu e. Phys Med. 2018 Apr;48:6-10. doi: 10.1016/j.ejmp.2018.03.006. Epub 2018 Mar 20. Phys Med. 2018. PMID: 29728230

6

Quantification of residual dose estimation error on log file-based patient dose calculation.

Katsuta Y, Kadoya N, Fujita Y, Shimizu E, Matsunaga K, Matsushita H, Majima K, Jingu K. Katsuta Y, et al. Among authors: shimizu e. Phys Med. 2016 May;32(5):701-5. doi: 10.1016/j.ejmp.2016.04.015. Epub 2016 May 6. Phys Med. 2016. PMID: 27162084

7

Clinical impact of dosimetric changes for volumetric modulated arc therapy in log file-based patient dose calculations.

Katsuta Y, Kadoya N, Fujita Y, Shimizu E, Matsunaga K, Matsushita H, Majima K, Jingu K. Katsuta Y, et al. Among authors: shimizu e. Phys Med. 2017 Oct;42:1-6. doi: 10.1016/j.ejmp.2017.08.004. Epub 2017 Aug 18. Phys Med. 2017. PMID: 29173901

8

Effects of Surgery With Salvage Stereotactic Radiosurgery Versus Surgery With Whole-Brain Radiation Therapy in Patients With One to Four Brain Metastases (JCOG0504): A Phase III, Noninferiority, Randomized Controlled Trial.

Kayama T, Sato S, Sakurada K, Mizusawa J, Nishikawa R, Narita Y, Sumi M, Miyakita Y, Kumabe T, Sonoda Y, Arakawa Y, Miyamoto S, Beppu T, Sugiyama K, Nakamura H, Nagane M, Nakasu Y, Hashimoto N, Terasaki M, Matsumura A, Ishikawa E, Wakabayashi T, Iwadate Y, Ohue S, Kobayashi H, Kinoshita M, Asano K, Mukasa A, Tanaka K, Asai A, Nakamura H, Abe T, Muragaki Y, Iwasaki K, Aoki T, Watanabe T, Sasaki H, Izumoto S, Mizoguchi M, Matsuo T, Takeshima H, Hayashi M, Jokura H, Mizowaki T, Shimizu E, Shirato H, Tago M, Katayama H, Fukuda H, Shibui S; Japan Clinical Oncology Group. Kayama T, et al. Among authors: shimizu e. J Clin Oncol. 2018 Jun 20:JCO2018786186. doi: 10.1200/JCO.2018.78.6186. Online ahead of print. J Clin Oncol. 2018. PMID: 29924704

9

Phase II trial of weekly paclitaxel in previously untreated advanced non-small-cell lung cancer.

Yasuda K, Igishi T, Kawasaki Y, Yamamoto M, Kato K, Matsumoto S, Kotani M, Sako T, Shigeoka Y, Sugitani A, Histuda Y, Shimizu E. Yasuda K, et al. Among authors: shimizu e. Oncology. 2003;65(3):224-8. doi: 10.1159/000074475. Oncology. 2003. PMID: 14657596 Clinical Trial.

10

Overexpression of constitutive signal transducer and activator of transcription 3 mRNA in cisplatin-resistant human non-small cell lung cancer cells.

Ikuta K, Takemura K, Kihara M, Nishimura M, Ueda N, Naito S, Lee E, Shimizu E, Yamauchi A. Ikuta K, et al. Among authors: shimizu e. Oncol Rep. 2005 Feb;13(2):217-22. Oncol Rep. 2005. PMID: 15643501

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

981 results

Search Page

Filters